Table 2.
Mean repeated positivity length based on the listed parameters.
| Parameter | Number with and without Assessed Parameter | Mean RSP (SD) Parameter Present | Mean RSP (SD) Parameter Absent | p-Value |
|---|---|---|---|---|
| Female | 55 | 47.7 (31.6) | − | 0.651 |
| Male | 67 | 46.7 (26.9) | − | |
| Comorbidities | ||||
| Hypertension | 22 vs. 60 | 44.8 (24.8) | 55.8 (32.5) | 0.379 |
| Chronic heart disease | 14 vs. 70 | 46.8 (20.2) | 53.6 (32.3) | 0.773 |
| Arrhythmia | 11 vs. 73 | 49.2 (23.3) | 53 (31.7) | 0.974 |
| T2DM | 19 vs. 63 | 46.2 (22.6) | 54.9 (32.8) | 0.271 |
| COPD | 6 vs. 76 | 61.8 (39.8) | 52.2 (30.3) | 0.345 |
| Chronic kidney disease | 5 vs. 77 | 46.6 (9.6) | 53.3 (31.7) | 0.651 |
| Chronic liver disease | 2 vs. 80 | 58 (38.2) | 52.7 (30.9) | 0.939 |
| Immunosuppression | 13 vs. 69 | 52.9 (33.7) | 51.6 (30.3) | 0.899 |
| Cancer | 3 vs. 81 | 72.7 (23.1) | 51.7 (30.7) | 0.123 |
| Other | 31 vs. 47 | 53.8 (27.3) | 52.7 (32.5) | 0.434 |
| First episode | ||||
| Mild COVID-19 | 46 | 51.3 (32.9) | − | 0.537 |
| Moderate COVID-19 | 40 | 54 (34.7) | − | |
| Severe COVID-19 | 16 | 41.1 (20.6) | − | |
| Critical COVID-19 | 7 | 34.4 (11.4) | − | |
| Hospitalization | 95 vs. 24 | 44.2 (29.3) | 64.6 (29.8) | 0.001 |
| Pneumonia | 46 vs. 16 | 42.8 (28.2) | 42.2 (28.9) | 0.342 |
| Fever | 76 vs. 32 | 48.1 (31.4) | 53.1 (32.1) | 0.638 |
| Cough | 67 vs. 41 | 47.7 (32.6) | 52.6 (30) | 0.209 |
| Dyspnea | 28 vs. 77 | 48.4 (25.6) | 50.7 (34) | 0.873 |
| Arthromyalgia | 20 vs. 88 | 46.7 (20.8) | 50.2 (33.6) | 0.687 |
| Headache | 13 vs. 95 | 63.8 (38.8) | 47.6 (30.1) | 0.042 |
| General cold symptoms | 19 vs. 89 | 53.6 (35.9) | 48.7 (30.7) | 0.475 |
| Asthenia | 14 vs. 95 | 46.2 (28) | 49.8 (32.1) | 0.942 |
| Gastrointestinal symptoms | 20 vs. 89 | 33.8 (10.5) | 52.8 (33.6) | 0.061 |
| Second episode | ||||
| Mild COVID-19 | 59 | 55.1 (37.8) | − | 0.377 |
| Moderate COVID-19 | 22 | 48.5 (18.7) | − | |
| Severe COVID-19 | 7 | 47.9 (13.1) | − | |
| Critical COVID-19 | 9 | 33.9 (11.4) | − | |
| Hospitalization | 87 vs. 24 | 44 (27.9) | 56.4 (37) | 0.148 |
| Pneumonia | 51 vs. 10 | 35.3 (12.9) | 70.8 (41) | 0.012 |
| Fever | 30 vs. 70 | 48.9 (26.1) | 51.9 (33) | 0.798 |
| Cough | 29 vs. 68 | 47.2 (26) | 53.5 (33.3) | 0.750 |
| Dyspnea | 27 vs. 73 | 48.3 (25) | 52 (33.1) | 0.661 |
| Arthromyalgia | 19 vs. 80 | 53 (28.2) | 50.6 (32) | 0.344 |
| Headache | 10 vs. 90 | 60.8 (35.3) | 49.9 (30.5) | 0.186 |
| General cold symptoms | 16 vs. 84 | 58.8 (36.6) | 49.5 (29.9) | 0.220 |
| Asthenia | 8 vs. 92 | 65.3 (38.1) | 49.8 (30.3) | 0.155 |
| Gastrointestinal symptoms | 9 vs. 91 | 39.1 (15.2) | 52.2 (32) | 0.511 |
COPD: chronic obstructive pulmonary disease; COVID-19: Coronavirus disease 2019; SD: standard deviation; RSP: repeatedly severe acute respiratory syndrome coronavirus 2 positivity; T2DM: type 2 diabetes mellitus. Minus sign means no data was available